# Neuritek Therapeutics, Inc.

Type: Company

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/neuritek-therapeutics-inc
Canonical HTML page: https://getbiobrief.com/entity/neuritek-therapeutics-inc

## Recent coverage (1 stories)

### Wellgistics Health Signs $105M LOI to Acquire Neuritek Therapeutics
2026-03-23 14:58:26 · Sentiment: Positive · Impact: 7/10 · Sources: 2

Wellgistics Health Inc. has entered into a non-binding Letter of Intent to acquire Neuritek Therapeutics for $105 million. The deal marks a significant strategic pivot for Wellgistics into the high-growth neurological and psychiatric drug development sector.
Full story: https://getbiobrief.com/story/wellgistics-health-neuritek-acquisition-loi

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.